We are live on !
Find out more
Novavax
NVAX
NVAX
89 hedge funds and large institutions have $142M invested in Novavax in 2013 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
45.37% more ownership
Funds ownership: 0% → 45.37% (+45%)
6% less call options, than puts
Call options by funds: $429K | Put options by funds: $454K
Holders
89
Holders Change
+89
Holders Change %
–
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
–
Increased
–
Reduced
–
Closed
–
Calls
$429K
Puts
$454K
Net Calls
-$25K
Net Calls Change
-$25K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
NVAX Hedge Fund Activity: Q2 2013 in Review
89 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2013, worth a combined $142M.
Fund positioning in NVAX was balanced in Q2 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 89 institutional investors held Novavax (NVAX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $142M of Novavax stock for Q2 2013.
- 0 funds opened new Novavax positions in Q2 2013 and 0 closed out.
Based on aggregated 13F filings for Q2 2013.